William F. Feehery
William F. Feehery's purchase track record
William F. Feehery has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/11/2025 | CERT | $200K | -18.4% | -40.7% | +8.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Certara analysts raise price targets, maintain positive outlook. TD Cowen kept its buy rating on Certara and lifted its price target to $11. Barclays also maintained an equal‑weight stance and increased its target to $9. A Yahoo analysis noted the company's fair‑value estimate moving higher as the turnaround gains traction. The upgrades suggest growing confidence among analysts.
Transaction History
| WST | ▲ Buy | Grant | 791 | $0 | 5/4/2026 | View on chart |
| CERT | ▲ Buy | Open Market | 24,096 | $200K | 11/11/2025 | View on chart |
| WST | ▲ Buy | Grant | 1,071 | $0 | 5/6/2025 | View on chart |
| CERT | ▲ Buy | Option Exercise | 36,580 | $0 | 4/1/2025 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 13,807 | $137K | 4/1/2025 | View on chart |
| CERT | ▲ Buy | Option Exercise | 33,220 | $0 | 4/1/2025 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 17,673 | $175K | 4/1/2025 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 14,116 | $140K | 4/1/2025 | View on chart |
| CERT | ▲ Buy | Option Exercise | 41,593 | $0 | 4/1/2025 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 8,238 | $82K | 4/1/2025 | View on chart |
| CERT | ▲ Buy | Grant | 29,960 | $0 | 4/1/2025 | View on chart |
| WST | ▲ Buy | Grant | 564 | $0 | 4/23/2024 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 12,971 | $232K | 4/1/2024 | View on chart |
| CERT | ▲ Buy | Option Exercise | 33,219 | $0 | 4/1/2024 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 14,115 | $252K | 4/1/2024 | View on chart |
| CERT | ▲ Buy | Option Exercise | 36,580 | $0 | 4/1/2024 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 15,543 | $278K | 4/1/2024 | View on chart |
| CERT | ▲ Buy | Grant | 59,799 | $0 | 3/5/2024 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 17,557 | $331K | 3/5/2024 | View on chart |
| WST | ▲ Buy | Grant | 616 | — | 4/25/2023 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 10,091 | $240K | 3/31/2023 | View on chart |
| CERT | ▲ Buy | Option Exercise | 36,580 | $0 | 3/31/2023 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 15,543 | $370K | 3/31/2023 | View on chart |
| WST | ▲ Buy | Grant | 632 | — | 5/24/2022 | View on chart |
| CERT | ▼ Sell | Tax Withholding | 9,255 | $199K | 4/1/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 62,485 | $1.3M | 3/16/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 27,515 | $558K | 3/11/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 70,294 | $1.6M | 2/18/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 4,706 | $113K | 2/18/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 6,518 | $166K | 2/17/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 53,407 | $1.3M | 2/17/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 30,075 | $750K | 2/17/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 51,196 | $1.3M | 1/26/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 23,804 | $588K | 1/26/2022 | View on chart |
| CERT | ▼ Sell | Open Market | 75,000 | $2.1M | 12/22/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 15,151 | $418K | 12/7/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 54,849 | $1.5M | 12/7/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 3,500 | $93K | 12/3/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 66,500 | $1.7M | 12/3/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 127,521 | $3.6M | 11/24/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 17,479 | $501K | 11/24/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 70,000 | $2.1M | 11/19/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 74,800 | $2.9M | 10/27/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 200 | $8K | 10/27/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 58,146 | $2.1M | 9/22/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 16,854 | $621K | 9/22/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 24,308 | $755K | 8/25/2021 | View on chart |
| CERT | ▼ Sell | Open Market | 50,692 | $1.6M | 8/25/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
West Pharmaceutical Services noted in analyst upgrade and market rally
West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.
West Pharmaceutical Services noted in analyst upgrade and market rally. West Pharmaceutical Services has risen about 36% year-to-date, drawing attention in recent market round-ups. TD Cowen kept its positive stance and lifted its price target to $420, citing the company's performance. The stock also appeared in CNBC’s final‑trade segment and in a dividend‑growth stock list, highlighting investor interest.